NEW YORK (GenomeWeb News) – NanoInk today announced a non-exclusive deal with Genetimes Technology for the distribution of NanoInk's products in China.

Under the terms of the deal, Genetimes will distribute the Skokie, Ill.-based company's desktop nanofabrication equipment, including the NLP 2000 System and DPN 5000 System. Further details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.